Cryptogenic stroke, aortic arch atheroma and patent foramen ovale

Cerebrovascular Diseases

Volumn 24, Issue SUPPL. 1, 2007, Pages 84-88

  Molina, Carlos A ^a   Santamarina, Estevo ^a   Alvarez Sabín, José ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Aortic atheroma; Brain embolism; Cryptogenic stroke; Patent foramen ovale

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

AGE; AORTA ARCH ATHEROMA; ATHEROMA; ATHEROSCLEROSIS; BRAIN EMBOLISM; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; DISEASE ASSOCIATION; HEART ATRIUM SEPTUM DEFECT; HUMAN; ISCHEMIA; LOW DRUG DOSE; PREVALENCE; PRIORITY JOURNAL; STROKE;

AORTA, THORACIC; ATHEROSCLEROSIS; FORAMEN OVALE, PATENT; HUMANS; STROKE;

EID: 35649015303     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107382     Document Type: Conference Paper

References (30)

1. Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, Wolf PA: Infarcts of undetermined cause: the NINCDS stroke data bank . Ann Neurol 1989;25:382-390.
2. Amarenco P, Duyckaerts C, Tzourio C, Henin D, Bousser MG, Hauw JJ: The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992;326:21-25.
3. Montgomery DH, Ververis JJ, McGorisk G, Frohwein S, Martin RP, Taylor WR: Natural history of severe atheromatous disease of the thoracic aorta: a transesophageal echocardiographic study. J Am Coll Cardiol 1996;27:95-101.
4. Geraci A, Weinberger J: Natural history of aortic arch atherosclerotic plaque. Neurology 2000;54:749-751.
5. Kazui S, Levi CR, Jones EF, Quang L, Calafior P, Donnan GA: Risk factors for lacunar stroke: a case-control transesophageal echocardiographic study. Neurology 2000;54:1385-1387.
6. Macleod MR, Amarenco P, Davis SM, Donnan GA: Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of stroke. Lancet Neurol 2004;3:408-414.
7. Amarenco P, Cohen A, Tzourio C, et al: Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994;331:1474-1479.
8. Ferrari E, Vida Rl, Chevallier T, Baudouy M: Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardiol 1999;33:1317-1322.
9. Matsumura Y, Osaki Y, Fukui T: Protruding atherosclerotic aortic plaques and dyslipidaemia: correlation to subtypes of ischaemic stroke. Eur J Echocardiogr 2002;3:8-12.
10. Rundek T, Di Tullio MR, Sciacca RR, et al: Association between large aortic arch atheromas and high-intensity transient signals in elderly stroke patients. Stroke 1999;33:2683-2686.
11. Castellanos M, Serena J, Segura T, Perez-Ayuso MJ, Silva A, Davalos A: Atherosclerotic aortic arch plaques in cryptogenic stroke: a microembolic signal monitoring study. Eur Neurol 2001;45:145-150.
12. Viguier A, Pavy le Traon A, Massabuau P, Valton L, Larrue V: Asymptomatic cerebral embolic signals in patients with acute cerebral ischaemia and severe aortic arch atherosclerosis. J Neurol 2001;248:768-771.
13. Jones EF, Kalman JM, Calafiore P, Tonkin AM, Donnan GA: Proximal aortic atheroma: an independent risk factor for cerebral ischemia. Stroke 1995;26:218-224.
14. Dressler FA, Craig WR, Castello R, Labovitz AJ: Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol 1998;31:134-138.
15. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography: Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998;128:639-647.
16. Diener HC, Bogousslavsky J, Brass LM: Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004;364:331-337.
17. Zabala JA, Amarenco P, Davis SM, Jones EF, Young D, Macleod MR, Horky L, Donnan GA: Aortic arch atheroma. Int J Stroke 2006;1:74-80.
18. Tunick PA, Nayar AC, Goodkin GM, Mirchandani S, Francescone S, Rosenzweig BP, Freeberg RS, Katz ES, Applebaum RM, Kronzon I: Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol 2002;90:1320-1325.
19. Homma S, Sacco RL: Patent foramen ovale. Circulation 2005;112:1063-1072.
20. Schereiter SW, Phillips JH: Thromboembolus traversing a patent foramen ovale: resolution with anticoagulation. J Am Soc Echocardiogr 1994;7:659-662.
21. Hust MH, Staiger M, Braun B: Migration of paradoxic embolus through a patent foramen ovale diagnosed by echocardiography: successful thrombolysis. Am Heart J 1995;129:620-622.
22. Hagen PT, Scholz DG, Edwards WD: Incidence and size of patent foramen ovale during the first 10 decades of life. Mayo Clin Proc 1984;59:17-20.
23. Homma S, Di Tullio MR, Sacco RL, Mihalatos D, Li Mandri G, Mohr JP: Characteristics of patent foramen ovale associated with cryptogenic stroke: a biplane transesophageal echocardiography study. Stroke 1994;25:582-586.
24. Serena J, Segura T, Perez-Ayuso MJ, Bassaganyas J, Molins A, Davalos A: The need to quantify right-to-left shunt in acute ischemic stroke: a case-control study. Stroke 1998;29:1322-1328.
25. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP, for the PFO in cryptogenic stroke (PICSS) investigators: Effect of medical treatment in stroke patients with foramen ovale: patent foramen ovale in cryptogenic stroke study. Circulation 2002;105:2625-2631.
26. Steiner MM, Di Tullio MR, Rundek T, Gan R, Chan X, Lugouri C, Brainin M, Homma S, Sacco RL: Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 1998;29:944-948.
27. Schuchlenz HW, Weihs W, Horner S, Quehenberger F: The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 2000;109:456-462.
28. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J: Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746.
29. Santamarina E, Gonzalez-Alujas T, Rubiera M, Ribo M, Rovira A, Evangelista A, Alvarez-Sabin J, Molina CA: Stroke pattern on DWI in patients with PFO and atrioseptal aneurysm. J Neuroimaging; in press.
30. Tong DC, Becker KJ: Patent foramen ovale and recurrent stroke: closure is the best option: no. Stroke 2004;35:804-805.